東京大学医学系研究科 国際保健政策学 東京大学 The University of Tokyo

Department of Global Health Policy

Graduate School of Medicine, The University of Tokyo

Manami Inoue

Project Professor, AXA Department of Health and Human Security / M.D., Ph.D., M.S.

井上 真奈美

Areas of interest

Descriptive and analytic epidemiology of cancer, population-based study, cancer registry methodology, cancer prevention, systematic reviews, meta-analysis, pooled analysis, cohort consortium, preventive medicine

Publications Click here contact mnminoue@m.u-tokyo.ac.jp

Career

2012-

Project Professor, AXA Department of Health and Human Security, Graduate School of Medicine, The University of Tokyo

2003-2012

Section Head, Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center

2002-2005

Epidemiology and Biostatistics Division, National Cancer Center Research Institute East (concurrent)

2002-2003

Senior Research Scientist, National Cancer Center Research Institute

1992-2002

Aichi-Prefectural Cancer Registry, Aichi Prefectural Government (concurrent)

1999-2002

Senior Research Scientist, Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute

1992-1999

Research Scientist, Division of Epidemiology, Aichi Cancer Center Research Institute

1996

M.S. in Epidemiology, Harvard University School of Public Health

1995

Ph.D., Nagoya University

1990

M.D., School of Medicine, University of Tsukuba

Publications

Svensson T, Yamaji T, Budhathoki S, Hidaka A, Iwasaki M, Sawada N, et al. Alcohol consumption, genetic variants in the alcohol- and folate metabolic pathways and colorectal cancer risk: the JPHC Study.Scientific Reports. 2016;6:36607.

Read the Article →

Saito I, Yamagishi K, Kokubo Y, Yatsuya H, Iso H, Sawada N, et al. Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study. International Journal of Cardiology. 2016; 222:281-6.

Read the Article →

Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Annals of Epidemiology. Online first.

Read the Article →

Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. Online First.

Read the Article →

GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1659-1724.

Read the Article →

GBD 2015 DALYS and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1603-1658.

Read the Article →

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1545-1602.

Read the Article →

GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016; 388(10053): 1459-1544.

Read the Article →

Kondo H, Soda M, Sawada N, Inoue M, Imaizumi Y, Miyazaki Y, et al. Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers. Cancer Causes and Control. 2016; 27(9): 1059-1066.

Read the Article →

Akter S, Kashino I, Mizoue T, Matsuo K, Ito H, Wakai K, et al.Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Japanese Journal of Clinical Oncology. 2016;46(8):781-7.

Read the Article →